- Global maker of high-purity inorganics and solvents used in pharmaceutical, diagnostic and industrial laboratory testing applications
- Transaction includes leading industry brands Fluka®, Hydranal® and Chromasolv®
- Broadens Honeywell's research chemicals portfolio and expands global reach
MORRIS PLAINS, N.J.,Oct. 20, 2015 /PRNewswire/ -- Honeywell (NYSE: HON) today announced that it has signed a definitive agreement to acquire the Seelze,Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately105 million euro.
The acquired Sigma-Aldrich business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications. The agreement is subject to customary closing conditions, including regulatory review.
"This acquisition allows Honeywell to offer laboratory customers a more complete product line, and builds on our already strong portfolio of Burdick & Jackson® high-purity solvents and reagents adding some of the industry's most well-known and respected brands," saidDarius Adamczyk, president and CEO of Honeywell Performance Materials and Technologies. "The acquisition will enable Honeywell to offer a broader line of inorganic chemicals and solvents for demanding applications ranging from pharmaceutical drug discovery to medical diagnostic testing."
Honeywell will acquire three global brands:
Fluka®chemicals and reagents used for biochemical research and other chemical and pharmaceutical applications; Hydranal®Karl Fischer titration reagents used by laboratories to measure moisture content in liquids and solids; Chromasolv® high-purity solvents for chromatography, a technique used to separate and analyze complex mixtures. All three product brands are globally recognized for their quality and lot-to-lot consistency, which is critical for a range of applications including drug synthesis, food, environmental, chemical and forensic testing.
"Customers of the Fluka, Hydranal, and Chromasolv brand solvents and inorganics will continue to get consistent, high-quality products from Honeywell. The combination of Honeywell's manufacturing expertise with the strength of an expanded solvents and inorganics portfolio will enable us to better serve all of our customers in research chemicals," continued Adamczyk. "Honeywell's strong business processes, and deployment of Honeywell Operating System, will allow us to optimize the production of Fluka, Hydranal, and Chromasolv brand products and grow the research chemicals business into new regions and customer segments."
The newly acquired business will be integrated into Honeywell's Fine Chemicals business, which has supplied high-quality research chemicals and specialty organic and inorganic compounds to the chemical and pharmaceutical industries for more than 100 years. It maintains laboratories and/or production facilities in Seelze,Germany andMuskegon, Michigan. Its products are sold under the Burdick & Jackson and Riedel-de Haen brands, and are used in a variety of laboratory, consumer and industrial applications including drug discovery, toothpaste, water purification, fortified foodstuffs, polymer synthesis, and metal surface treatment and finishing.
Sigma-Aldrich is a leading life science and high technology company that provides chemical and biochemical products and kits for scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and in pharmaceutical, diagnostic and other high technology manufacturing.
Honeywell Fine Chemicals is a part of the Honeywell Performance Materials and Technologies business group.
Honeywell Performance Materials and Technologies (PMT) is a global leader in developing advanced materials, process technologies and automation solutions. PMT's Advanced Materials businesses manufacture a wide variety of high-performance products, including environmentally friendlier refrigerants and materials used to manufacture end products such as bullet-resistant armor, nylon, computer chips and pharmaceutical packaging. Process technologies developed by PMT's UOP business (www.uop.com) form the foundation for most of the world's refiners, efficiently producing gasoline, diesel, jet fuel, petrochemicals and renewable fuels. PMT's Process Solutions business (www.honeywellprocess.com) is a pioneer in automation control, instrumentation and services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, and metals, minerals and mining industries.
Honeywell (www.honeywell.com) is a Fortune 100 diversified technology and manufacturing leader, serving customers worldwide with aerospace products and services; control technologies for buildings, homes, and industry; turbochargers; and performance materials. For more news and information on Honeywell, please visit www.honeywellnow.com.
This release contains certain statements that may be deemed "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, that address activities, events or developments that we or our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Such statements are based upon certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. Such forward-looking statements are not guarantees of future performance, and actual results, developments and business decisions may differ from those envisaged by such forward-looking statements. We identify the principal risks and uncertainties that affect our performance in our Form 10-K and other filings with the Securities and Exchange Commission.